Hainan Haiyao Co Ltd
SZSE:000566
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hainan Haiyao Co Ltd
Revenue
Hainan Haiyao Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hainan Haiyao Co Ltd
SZSE:000566
|
Revenue
¥831.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-7%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥15B
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥32.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥41.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Revenue
¥22.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Revenue
¥5.8B
|
CAGR 3-Years
94%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Hainan Haiyao Co Ltd
Glance View
Hainan Haiyao Co., Ltd. engages in the research and development, production, and sales of pharmaceuticals and medical devices. The company is headquartered in Haikou, Hainan and currently employs 2,589 full-time employees. The Company’s main products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The firm distributes its products in domestic market and to overseas market, with China as its main market.
See Also
What is Hainan Haiyao Co Ltd's Revenue?
Revenue
831.2m
CNY
Based on the financial report for Dec 31, 2025, Hainan Haiyao Co Ltd's Revenue amounts to 831.2m CNY.
What is Hainan Haiyao Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
-7%
Over the last year, the Revenue growth was -16%. The average annual Revenue growth rates for Hainan Haiyao Co Ltd have been -22% over the past three years , -18% over the past five years , and -7% over the past ten years .
